Hester Biosciences P/B Ratio

Current P/B Ratio
4.44
High Valuation
Very High - Significant premium, high growth expectations or speculative

Hester Biosciences (HESTERBIO) P/B ratio is 4.44 (High), book value per share ₹400.00 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. View HESTERBIO annual price range for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 4.44
Current Price ₹1990.00
Book Value/Share ₹400.00
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹360 Cr
Share Capital ₹9 Cr
Reserves & Surplus ₹352 Cr
Outstanding Shares 9,000,000
Book Value per Share ₹400.00

Valuation Signal

Signal Overvalued
Historical Avg 5.42
Historical Range 4.4 - 7.13
Percentile 20.0%

Sector Context

Sector Average -0.33
Sector Median 0.63
Sector Rank #11 of 50
Sector Percentile 22.0%

HESTERBIO P/B Ratio — Valuation Insights & Book Value Analysis

Hester Biosciences price-to-book ratio interpretation, valuation status and historical context — current P/B 4.44 (High). Compare with HESTERBIO DCF valuation to assess whether the stock is under or overvalued.

  • Stock appears overvalued with PB of 4.44, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Trading at premium to sector average PB of -0.33

Hester Biosciences P/B Ratio Historical Trend

HESTERBIO annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see HESTERBIO share price.

HESTERBIO Historical P/B Ratio — Book Value Per Share & Year-End Price

Hester Biosciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 4.97 ₹400.0 ₹1990.00 ₹360 High
2025 4.4 ₹363.33 ₹1599.70 ₹327 High
2024 7.13 ₹336.67 ₹2399.40 ₹303 High
2023 4.54 ₹321.11 ₹1457.90 ₹289 High
2022 6.04 ₹296.67 ₹1791.65 ₹267 High

HESTERBIO vs Healthcare Peers — P/B Ratio Comparison

Hester Biosciences P/B 4.44 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.

Sector Average
-0.33
Sector Median
0.63
Lowest P/B
-17.92
Highest P/B
1.01
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.92 ₹22 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Parmax Pharma PARMAX -2.48 ₹14 Low
Bharat Immunologicals BIBCL -2.32 ₹76 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹127 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.63 ₹53 Low